SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-097523
Filing Date
2014-03-13
Accepted
2014-03-13 15:24:52
Documents
3
Period of Report
2014-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d692977d8k.htm 8-K 15432
2 EX-99.1 d692977dex991.htm EX-99.1 57557
3 GRAPHIC g692977g06u73.jpg GRAPHIC 24625
  Complete submission text file 0001193125-14-097523.txt   108495
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 14690812
SIC: 3841 Surgical & Medical Instruments & Apparatus